Statistics
Publications
2
Citations
142
H-Index
2
Active since
2022
Rengyi Xu is an author at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico specializing in clinical pharmacology, hematology, and pharmacology.
Publications per year
2022–2022
2
2
Mitapivat versus Placebo for Pyruvate Kinase Deficiency
Hanny Al‐Samkari, F. Galactéros, Andreas Glenthøj et al. · New England Journal of Medicine · 2022 · 94 citations · Full text
Medicine, Hematology, Pharmacology +13
Andreas Glenthøj, Eduard J. van Beers, Hanny Al‐Samkari et al. · The Lancet Haematology · 2022 · 48 citations
Medicine, Hematology, Pharmacology +12
1–2 of 2